Prof Kenneth Cusi, USA, discusses the role of insulin sensitizers in NASH, and particularly how lifestyle interventions including weight loss can, in this context, be beneficial together with a pharmacological approach. This video was filmed in Boston during the Liver meeting 2019.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.